Establish Your Innovation Hub at RESI JPM 2027

August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

Every January, JPM Healthcare Week transforms San Francisco into the global center of the life science industry, bringing together investors, pharmaceutical executives, biotech leaders, and innovators from around the world. For organizations looking to showcase their regional ecosystem, portfolio companies, or innovation network, RESI JPM 2027 offers a unique opportunity to establish a visible and strategic presence during one of the industry’s most influential weeks.

Located within the San Francisco Marriott Marquis, RESI JPM is the premier partnering conference dedicated to early-stage life science companies. The event connects startups with active investors, strategic partners, and business development professionals through curated partnering meetings, educational programming, and networking opportunities.

Life Science Nation invites regional organizations, innovation hubs, accelerators, and industry partners to create their own branded Innovation Hub alongside RESI JPM. These flexible hosting opportunities allow organizations to provide a central gathering place for their ecosystem while taking advantage of the high concentration of attendees already participating in RESI and JPM Healthcare Week.

RESI JPM 2027 Venue: Salons 9–15 (Yerba Buena Ballroom, Lower B2 Level) with total space exceeding 17,000 sq ft.

Organizations can kick off the week with a private networking reception on Sunday, welcoming investors, founders, corporate partners, and key stakeholders before the week’s meetings begin. During RESI JPM on Monday and Tuesday, dedicated salon spaces adjacent to the conference offer an ideal location for hosting meetings, showcasing portfolio companies, conducting presentations, and serving as a home base for delegates throughout the event.

Tech/Innovation hubs also benefit from prominent branding within the RESI environment and the opportunity for their startup cohorts to engage directly in RESI’s partnering platform, creating additional exposure and meeting opportunities with investors and strategic partners.

Whether representing a regional life science cluster, government agency, incubator, accelerator, or investment organization, establishing an Innovation Hub at RESI JPM positions your organization at the center of the world’s largest life science partnering week while providing lasting value for your innovation ecosystem.

To learn more about creating an Innovation Hub at RESI JPM 2027, contact Life Science Nation at salescore@lifesciencenation.com.

Meet the First Believers: The Investors Behind Tomorrow’s Breakthrough Companies

August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Momo Yamamoto, Senior Investor Research Analyst, LSN

Every successful life science company has a defining moment in its fundraising journey. Long before a major venture capital round or strategic partnership, there is often an investor willing to take the very first leap of faith.

At 9:00 AM on Wednesday, September 23, Day 2 of RESI Boston 2026 begins with one of the conference’s most valuable discussions for early-stage founders: The First Believers: The Investors Behind Tomorrow’s Breakthrough Companies.

Securing that first investment is about much more than capital. Early investors provide critical validation, open doors to strategic relationships, and help companies build the momentum needed to attract future financing. Understanding how these investors think can give entrepreneurs a significant advantage as they prepare for fundraising.

This panel brings together accomplished investors and innovation leaders who regularly evaluate breakthrough technologies at their earliest stages:

Renaud Jacquemart Omnium Global (Moderator)	Sam Gussman-Toh ARPA-H	William Hsu, PhD NuFund Venture Group
Rohit Jain HBS Alumni Angels of Northern California	Dushyant Pathak Autobahn Labs

These panelists represent a diverse range of perspectives across venture creation, angel investing, government-supported innovation, and early-stage venture capital. Collectively, they helped identify and support companies long before they became widely recognized.

During the discussion, attendees will gain insight into what separates promising startups from investable opportunities. The panel will explore the characteristics investors look for in founding teams, the technical and commercial milestones that inspire confidence, and the common mistakes entrepreneurs make when approaching investors during the earliest stages of fundraising.

The conversation will also address how startups can build credibility before institutional financing, demonstrate meaningful progress with limited resources, and develop fundraising strategies that position them for long-term success.

For founders preparing to raise their first outside capital, this session offers a rare opportunity to hear directly from the investors who are often the first to believe in transformative science and technology.

Whether you are refining your investment story, preparing for investor meetings, or mapping out your fundraising roadmap, The First Believers panel will provide practical insights that can help shape your next steps.

Don’t miss this opportunity to kick off Day 2 of RESI Boston with an inside look at how early-stage investors identify the breakthrough companies of tomorrow.

Build an Investor-Ready Company with Life Science Nation’s Education Program

August 4, 2026August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, VP of Product, Israel BD, LSN

Raising capital is more than having innovative science. Early-stage life science companies also need a compelling story, a clear fundraising strategy, and the ability to engage the right investors. Life Science Nation’s (LSN) Education Program helps founders build those skills, preparing them for a successful fundraising campaign that typically spans 9 to 18 months.

Designed for biotechnology, medical device, diagnostics, digital health, and life science tool companies, the program gives entrepreneurs practical guidance while helping accelerators, incubators, universities, and regional innovation organizations better prepare their portfolio companies for investor engagement.

Two Programs, One Goal
Organizations can choose the level of support that best fits their companies’ needs.

Preparing and Executing a RESI Event includes:

Three virtual education sessions
In-person Pitch Practice and Shark Tank before RESI

Preparing and Executing a Global Roadshow includes:

Twelve virtual education sessions
A dedicated LSN mentor with coaching between classes
In-person Pitch Practice and Shark Tank

Throughout the curriculum, founders learn how investors evaluate opportunities, refine their branding and messaging, align fundraising goals with company milestones, and develop a systematic approach to investor outreach. Participants also learn how to navigate the RESI Partnering Platform, identify the right investors, execute productive meetings, and build an effective follow-up strategy after the conference.

The program concludes with an in-person Pitch Practice and Shark Tank held before RESI, giving companies the opportunity to present their technology, receive live feedback, and strengthen their investor presentations before meeting with active investors.

Putting Preparation into Practice

The Education Program is designed to prepare companies for the Redefining Early Stage Investments (RESI) Conference Series, where startups connect with active investors, pharmaceutical companies, strategic partners, and service providers from across the global life science ecosystem.

Companies can further increase their visibility by participating in the Innovator’s Pitch Challenge (IPC). Each company delivers a six-minute presentation followed by seven minutes of investor Q&A, while also showcasing its technology in the RESI Exhibition Hall. IPC participants receive additional exposure through the LSN Newsletter and RESI Program Guide, with audience voting determining the competition winners.

Together, the Education Program, RESI Conference, and Innovator’s Pitch Challenge provide founders with a complete framework for fundraising success—from developing an investor-ready message to building meaningful relationships that can help move their companies forward.

Interested in bringing the Life Science Nation Education Program to your portfolio companies? Visit www.lifesciencenation.com and www.resiconference.com to learn more.

Introducing Investor Reverse Pitch at RESI Boston 2026 – Hear directly from the investors shaping the life science and healthcare startup ecosystem

July 28, 2026July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Joey Wong, Director of Investor Research, Hong Kong BD, LSN

Fundraising is a two-way conversation. While startups regularly pitch to investors, it is equally valuable for entrepreneurs to understand what investors are looking for and the unique value they can bring beyond providing capital.

This year at RESI Boston 2026, we are excited to introduce a new Investor Reverse Pitch, a dedicated session where investors will take the stage. Unlike traditional startup pitch sessions, where companies present their technologies and business models, Investor Reverse Pitch puts the spotlight on investors. Participating investors will introduce their fund, share their investment thesis, highlight the opportunities they are currently seeking, and most importantly, showcase the unique value proposition they bring to the startups they back and what it is like to work with them as a partner.

Each presenter will have 5 minutes to pitch, followed by 6-7 minutes of audience Q&A. Founders can come prepared with their most pressing questions, learn how investors evaluate opportunities, and identify the partners who may be the best fit for their companies.

For early-stage founders, this is an excellent opportunity to gain direct insight into investor priorities, better position their fundraising strategies, and make their one-on-one meetings at RESI more focused and productive. For investors, it is your chance to highlight your thesis, attract relevant deal flow, and connect with founders whose technologies and goals closely align with your mandate.

Call for Speakers

We are currently seeking investors and strategic partners to participate in the Investor Reverse Pitch at RESI Boston 2026. The sessions will take place on Wednesday, September 23rd at the Westin Copley Place in Boston.

If you are interested in presenting at the Investor Reverse Pitch, please reach out to research@lifesciencenation.com. We look forward to working with you on this exciting new addition to RESI!

Apply to Investor Reverse Pitch

Meet the Investors Shaping the Future of Life Science Innovation

July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Momo Yamamoto, Senior Investor Research Analyst, LSN

One of the most valuable aspects of attending RESI Boston is the opportunity to hear directly from the investors and strategic partners actively funding and partnering with early-stage life science companies.

This year’s agenda features an outstanding lineup of leaders representing global pharmaceutical companies, venture capital firms, strategic investors, government funding organizations, and mission-driven investment groups. Their sessions will provide firsthand insights into today’s investment landscape, what they look for in emerging technologies, and how startups can position themselves for successful fundraising and partnership discussions.

Farnaz Bakhshi American Cancer Society BrightEdge	Alan Chiu Breakthrough T1D	Yvanka de Soysa Foreground Capital
Shane Duffy Avanos Medical	Nimisha Gupta Jazz Pharmaceuticals	Sam Gussman-Toh ARPA-H
Jonathan Illicki Industrifonden	Nikhil Mutyal AstraZeneca	Rohit Nuwal TELUS Ventures
Parthiban Rajasekaran Sanofi	Armin Rump Otsuka Pharmaceutical Co., Ltd

Register Today for RESI Boston 2026

Don’t miss your opportunity to learn directly from these industry leaders while connecting with hundreds of active investors, strategic partners, and innovative life science companies during Biotech Week Boston.

Join us September 22–23 in Boston, followed by three days of virtual partnering on September 25, 28, and 29.

Register now to secure your spot, take advantage of Early Bird savings, and begin scheduling meetings with the global life science investment community.

Gearing Up for RESI Boston: Master Your Fundraising & Development Strategy at the Pre-RESI Biotech Forum

July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

On Monday, September 21, 2026, the day before RESI Boston 2026, Life Science Nation (LSN) and RESI Boston Silver Sponsor, Certara, will host a Biotech Forum focused on Developing Investor Ready Strategies.

Designed for early-stage biotech companies, the workshop will help founders evaluate their company’s readiness for a global fundraising campaign by identifying opportunities to strengthen their development strategy and reduce key scientific, clinical, regulatory, commercial, and fundraising risks. Through expert-led sessions and interactive discussions, attendees will gain practical insights into what investors look for during diligence, how to build a credible development roadmap, and how to position their company for successful fundraising.

Held immediately before RESI Boston, the workshop gives companies the opportunity to refine their strategy and messaging before meeting with investors and strategic partners throughout RESI.

Not yet signed up for RESI Boston 2026: Register Here

We look forward to welcoming you to the CIC in Cambridge as we kick off RESI Boston 2026 with a day dedicated to helping innovative biotech companies become truly investor ready.

Cross-Border Investor Luncheon at RESI Boston 2026

July 21, 2026July 24, 2026 ~ Next Phase Admin ~ Leave a comment

A private, screened luncheon for regional and international investors seeking syndicate partners.

RESI Boston | Wednesday, September 23 | 75 Seats

RSVP for Cross-Border Investor Luncheon Today

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

Nearly nine out of ten life science startups fail. Not because the science is poor, but because they never connect to the right capital and strategic partners. Solving that is the reason Life Science Nation exists, and for more than fifteen years our work has come down to one thing: finding parties who need each other and matching them.

As some readers know, LSN has been addressing this pervasive dilemma through the LSN Labs Anchor Node Program. An Anchor Node combines LSN’s commercialization methodology and global capital formation network with a regional partner’s laboratories, entrepreneurial programs, and operating platform to produce investment-ready life science companies.

As we expanded the Anchor Node Program across Boston, Australia, Japan, Korea, the UK, and Brazil, a clear pattern emerged: regional partners constantly brought their local VCs to the table seeking international capital. At the same time, our own data across five global RESI events revealed that twenty percent of all partnering meetings were already investor-to-investor.

So we decided to formalize it, and provide a dedicated room for these partners to connect.

The Cross-Border Investor Luncheon, CBIL, is a private luncheon at RESI Boston for regional and international investors seeking syndicate partners. Regional investors have access to exceptional companies that often never reach international investors. International investors have access and reach that regional funds cannot build alone. Both are looking for the same thing across Asia, Europe, North America, and South America.

Attendance is screened. CBIL is for active investors seeking syndicate partners outside their own region, whether that means bringing international capital into local deals or gaining access to deal flow in regions where they have no presence.

Taking place on Wednesday, September 23, CBIL follows the format of the Global Family Office BioForum luncheon (GFOB luncheon takes place on Tuesday, September 22), now in its eighth year. Across those eight years, GFOB has brought family offices together to find each other, form alliances, and build syndicates. CBIL is the natural next step, applying the same private, curated format to the international investor community.

“The future of life science investing is not just finding great companies. It is finding great syndicate partners in the global arena.”

Dennis Ford, Founder and CEO, Life Science Nation

Wednesday, September 23 | Private luncheon | Screened RSVP | 75 seats

Every RSVP is reviewed. Request your seat today!

RSVP for Cross-Border Investor Luncheon Today